The 156th session of the World Health Organization (WHO) Executive Board was held in Geneva, Switzerland, from Feb 3 to 11. Around 800 representatives from WHO member states, relevant international organizations and non-governmental organizations attended the meeting.

The Chinese delegation comprised representatives from relevant departments of the National Health Commission, the Ministry of Foreign Affairs, the Ministry of Ecology and Environment, the National Administration of Traditional Chinese Medicine, the National Disease Control and Prevention Administration, the National Healthcare Security Administration, and the National Medical Products Administration, the Permanent Mission of China to the United Nations Office at Geneva as well as relevant experts.

In his report at the session, WHO Director-General Tedros Adhanom Ghebreyesus reviewed the organization's work in improving access to health services and responding to public health emergencies and financing in 2024, calling on the countries involved to increase their support for the WHO so as to achieve the highest attainable standard of health for all at an early date.

The session discussed over 40 topics, including primary healthcare, mental health, human resources for health and public health emergencies, and deliberated more than 20 draft resolutions on issues such as rare diseases, strengthening health financing and enhancing national capacity for evidence-based decision-making.

The Chinese delegation played an active part in the discussions on various topics, commended the work done by the WHO, and expressed support for the organization in playing a leading and coordinating role in global health governance. The delegation also shared Chinese experience in relevant fields and called on the WHO to focus on its primary responsibilities and work to further improve efficiency and performance.

They said China is ready to promote cooperation with all parties involved so as to jointly advance the building a global community of health for all.